Abstract：
Following the publication of the above paper, the authors have realized that the cell apoptosis and cell proliferation assays in Fig. 8 were poorly presented, which made the interpretation of the data difficult. Furthermore, a change was also required to the text concerning the description of Fig. 8: The sentence starting on p. 517, left‑hand column, line 7 (\'The fraction of apoptotic cells was 22.41±2.596 in the lncENST00000444102-overexpressing SKM‑1 cells, and 8.650±0.889 in the negative control; the fraction of apoptotic cells was 20.58±2.190 in the lncENST00000444102‑overexpressing THP‑1 cells and 8.192±0.997 in the negative control group (P<0.001, Fig. 8B)\' should be replaced with the following text: \'Flow cytometry showed that the fraction of apoptotic cells increased in the lncENST00000444102‑overexpressing SKM‑1 and THP‑1 cells, as determined by Annexin V‑APC/7-AAD staining at 48 h (P<0.05; Fig. 8B)\'. A revised version of Fig. 8, presenting the results of the flow cytometric analysis more clearly, is shown on the next page. Note that the revisions made to this figure have not had a major impact on the reported results, and do not affect the overall conclusions reported in the study. All the authors agree to the publication of this corrigendum. The authors are grateful to the Editor of Oncology Reports for allowing them the opportunity to publish this Corrigendum; furthermore, they apologize for any inconvenience caused to the readership of the Journal. [Oncology Reports 42: 509‑520, 2019; DOI: 10.3892/or.2019.7175].
摘要：
上述论文发表后，作者已经意识到，细胞凋亡和细胞增殖测定在图。8人表现不佳，这使得数据的解释变得困难。此外，还需要对有关图的描述的文本进行更改。8：从第517页开始的句子，左栏，第7行（在lncENST00000444102过表达SKM‑1细胞中，凋亡细胞的比例为22.41±2.596，阴性对照组为8.650±0.889；lncENST00000444102过表达THP‑1细胞的凋亡细胞比例为20.58±2.190，阴性对照组为8.192±0.997（P<0.001，图。8B）应替换为以下文字：流式细胞术显示，在lncENST00000444102过表达的SKM‑1和THP‑1细胞中，凋亡细胞的比例增加，通过膜联蛋白V‑APC/7-AAD染色在48小时测定（P<0.05；图。8B)\'。图的修订版。8，更清楚地呈现流式细胞仪分析的结果，显示在下一页上。请注意，对该数字进行的修订并未对报告的结果产生重大影响，并且不影响研究报告的总体结论。所有作者都同意本更正的出版。作者感谢《肿瘤学报告》编辑允许他们有机会发表本更正；此外，对于给《华尔街日报》读者带来的不便，他们深表歉意。[肿瘤学报告42：509-520，2019年；DOI：10.3892/or.2019.7175]。
